Microdissected pancreatic cancer proteomes reveal tumor heterogeneity and therapeutic targets
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Microdissected pancreatic cancer proteomes reveal tumor heterogeneity and therapeutic targets
Authors
Keywords
-
Journal
JCI Insight
Volume 5, Issue 15, Pages -
Publisher
American Society for Clinical Investigation
Online
2020-07-08
DOI
10.1172/jci.insight.138290
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- FHL3 promotes pancreatic cancer invasion and metastasis through preventing the ubiquitination degradation of EMT associated transcription factors
- (2020) Pengping Li et al. Aging-US
- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Predicted Prognosis of Pancreatic Cancer Patients by Machine Learning
- (2020) Seiya Yokoyama et al. CLINICAL CANCER RESEARCH
- Unsupervised class discovery in pancreatic ductal adenocarcinoma reveals cell-intrinsic mesenchymal features and high concordance between existing classification systems
- (2020) Frederike Dijk et al. Scientific Reports
- High‐grade mesenchymal pancreatic ductal adenocarcinoma drives stromal deactivation through CSF‐1
- (2020) Anne Steins et al. EMBO REPORTS
- Experimental microdissection enables functional harmonisation of pancreatic cancer subtypes
- (2019) Hans Carlo Maurer et al. GUT
- A deep proteome and transcriptome abundance atlas of 29 healthy human tissues
- (2019) Dongxue Wang et al. Molecular Systems Biology
- Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma
- (2019) Junya Peng et al. CELL RESEARCH
- Tumor cell–intrinsic EPHA2 suppresses antitumor immunity by regulating PTGS2 (COX-2)
- (2019) Nune Markosyan et al. JOURNAL OF CLINICAL INVESTIGATION
- Upregulation of Mobility in Pancreatic Cancer Cells by Secreted S100A11 Through Activation of Surrounding Fibroblasts
- (2019) Yosuke Mitsui et al. ONCOLOGY RESEARCH
- Proteomic analyses of ECM during pancreatic ductal adenocarcinoma progression reveal different contributions by tumor and stromal cells
- (2019) Chenxi Tian et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
- (2018) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Splicing modulation as novel therapeutic strategy against diffuse malignant peritoneal mesothelioma
- (2018) Rocco Sciarrillo et al. EBioMedicine
- Esophageal Adenocarcinoma Cells and Xenograft Tumors Exposed to Erb-b2 Receptor Tyrosine Kinase 2 and 3 Inhibitors Activate Transforming Growth Factor Beta Signaling, Which Induces Epithelial to Mesenchymal Transition
- (2017) Eva A. Ebbing et al. GASTROENTEROLOGY
- Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
- (2017) Daniel Öhlund et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
- (2017) John P Neoptolemos et al. LANCET
- Prognostic value of GLUT-1 expression in pancreatic cancer: results from 538 patients
- (2017) Gaowa Sharen et al. Oncotarget
- Targeting calcium signaling in cancer therapy
- (2017) Chaochu Cui et al. Acta Pharmaceutica Sinica B
- A COL11A1-correlated pan-cancer gene signature of activated fibroblasts for the prioritization of therapeutic targets
- (2016) Dongyu Jia et al. CANCER LETTERS
- A Novel MIF Signaling Pathway Drives the Malignant Character of Pancreatic Cancer by Targeting NR3C2
- (2016) Shouhui Yang et al. CANCER RESEARCH
- Mass-spectrometric exploration of proteome structure and function
- (2016) Ruedi Aebersold et al. NATURE
- Genomic analyses identify molecular subtypes of pancreatic cancer
- (2016) Peter Bailey et al. NATURE
- Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression
- (2016) Hanane Laklai et al. NATURE MEDICINE
- Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy
- (2016) Hong Jiang et al. NATURE MEDICINE
- Calretinin but not caveolin-1 correlates with tumour histology and survival in malignant mesothelioma
- (2016) Bibhusal Thapa et al. PATHOLOGY
- Meta-analysis of transcriptome data identifies a novel 5-gene pancreatic adenocarcinoma classifier
- (2016) Manoj K. Bhasin et al. Oncotarget
- Feasibility of label-free phosphoproteomics and application to base-line signaling of colorectal cancer cell lines
- (2015) Sander R. Piersma et al. Journal of Proteomics
- Carboxylesterase 2 as a Determinant of Response to Irinotecan and Neoadjuvant FOLFIRINOX Therapy in Pancreatic Ductal Adenocarcinoma
- (2015) Michela Capello et al. JNCI-Journal of the National Cancer Institute
- Myostatin and IGF-I signaling in end-stage human heart failure: a qRT-PCR study
- (2015) Júlia Baán et al. Journal of Translational Medicine
- Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma
- (2015) Richard A Moffitt et al. NATURE GENETICS
- limma powers differential expression analyses for RNA-sequencing and microarray studies
- (2015) Matthew E. Ritchie et al. NUCLEIC ACIDS RESEARCH
- 2016 update of the PRIDE database and its related tools
- (2015) Juan Antonio Vizcaíno et al. NUCLEIC ACIDS RESEARCH
- Carboxylesterase 2 as a Determinant of Response to Irinotecan and Neoadjuvant FOLFIRINOX Therapy in Pancreatic Ductal Adenocarcinoma
- (2015) Michela Capello et al. JNCI-Journal of the National Cancer Institute
- Conducting Meta-Analyses inRwith themetaforPackage
- (2015) Wolfgang Viechtbauer Journal of Statistical Software
- An assessment of computational methods for estimating purity and clonality using genomic data derived from heterogeneous tumor tissue samples
- (2014) V. K. Yadav et al. BRIEFINGS IN BIOINFORMATICS
- Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma
- (2014) Andrew D. Rhim et al. CANCER CELL
- TRIM29 as a Novel Biomarker in Pancreatic Adenocarcinoma
- (2014) Hongli Sun et al. DISEASE MARKERS
- A Novel Chimeric Antigen Receptor Against Prostate Stem Cell Antigen Mediates Tumor Destruction in a Humanized Mouse Model of Pancreatic Cancer
- (2014) Daniel Abate-Daga et al. HUMAN GENE THERAPY
- Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling
- (2014) Katia Nones et al. INTERNATIONAL JOURNAL OF CANCER
- Genetic and pharmacologic inhibition of EPHA2 promotes apoptosis in NSCLC
- (2014) Katherine R. Amato et al. JOURNAL OF CLINICAL INVESTIGATION
- Stars and stripes in pancreatic cancer: role of stellate cells and stroma in cancer progression
- (2014) Jeremy S. Wilson et al. Frontiers in Physiology
- Calretinin expression in high-grade invasive ductal carcinoma of the breast is associated with basal-like subtype and unfavorable prognosis
- (2013) Ross J. Taliano et al. HUMAN PATHOLOGY
- Calretinin is essential for mesothelioma cell growth/survival in vitro: A potential new target for malignant mesothelioma therapy?
- (2013) Walter Blum et al. INTERNATIONAL JOURNAL OF CANCER
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Overexpression of COL11A1 by Cancer-Associated Fibroblasts: Clinical Relevance of a Stromal Marker in Pancreatic Cancer
- (2013) Carmen García-Pravia et al. PLoS One
- Whole gel processing procedure for GeLC-MS/MS based proteomics
- (2013) Sander R Piersma et al. Proteome Science
- Inferring tumour purity and stromal and immune cell admixture from expression data
- (2013) Kosuke Yoshihara et al. Nature Communications
- The good, the bad and the ugly: a tale of miR-101, miR-21 and miR-155 in pancreatic intraductal papillary mucinous neoplasms
- (2012) S. Caponi et al. ANNALS OF ONCOLOGY
- Optimized nLC-MS workflow for laser capture microdissected breast cancer tissue
- (2012) René B.H. Braakman et al. Journal of Proteomics
- Involvement of annexin A8 in the properties of pancreatic cancer
- (2012) Harumi Hata et al. MOLECULAR CARCINOGENESIS
- Google Goes Cancer: Improving Outcome Prediction for Cancer Patients by Network-Based Ranking of Marker Genes
- (2012) Christof Winter et al. PLoS Computational Biology
- Critical role of laser microdissection for genetic, epigenetic and proteomic analyses in pancreatic cancer
- (2011) Niccola Funel et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy
- (2011) Eric A Collisson et al. NATURE MEDICINE
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Migration Signature and Plasma Biomarker Panel for Pancreatic Adenocarcinoma
- (2010) S. Balasenthil et al. Cancer Prevention Research
- Hallmarks of cancer: Interactions with the tumor stroma
- (2010) Kristian Pietras et al. EXPERIMENTAL CELL RESEARCH
- Regularized gene selection in cancer microarray meta-analysis
- (2009) Shuangge Ma et al. BMC BIOINFORMATICS
- Derlin-1 Is Overexpressed on the Tumor Cell Surface and Enables Antibody-Mediated Tumor Targeting Therapy
- (2008) Y. Ran et al. CLINICAL CANCER RESEARCH
- MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification
- (2008) Jürgen Cox et al. NATURE BIOTECHNOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started